Showing results (481-490 of 502) with videos related to

Sort By:
Pageof 51
Metabolic Engineering|April 25, 2012
Metabolic engineering of β-oxidation in Penicillium chrysogenum for improved semi-synthetic cephalosporin biosynthesisTânia Veiga, Andreas K Gombert, Nils Landes, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2017
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndromeOmer Schwartzman, Angela Maria Savino, Michael Gombert, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registryJacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, et al.
Translational Psychiatry|December 6, 2012
Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorderH Perron, N Hamdani, R Faucard, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 13, 2025
European Society for Vascular Surgery (ESVS) 2025 Clinical Practice Guidelines on the Management of Diseases of the Mesenteric and Renal Arteries and VeinsMark J Koelemay, Robert H Geelkerken, Jussi Kärkkäinen, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Characterization of mutations in ATP8B1 associated with hereditary cholestasisLeo W J Klomp, Julie C Vargas, Saskia W C van Mil, et al.
Blood Advances|October 25, 2019
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targetsJessica I Hoell, Sebastian Ginzel, Michaela Kuhlen, et al.
Rheumatology (Oxford, England)|November 3, 2021
New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL studyJean-Guillaume Letarouilly, Thao Pham, Adeline Pierache, et al.
Pageof 51